An in vitro model of ciprofloxacin and minocycline transport by oral epithelial cells

Journal of Periodontology

Volumn 73, Issue 11, 2002, Pages 1267-1272

  Brayton, James J ^a   Yang, Qing ^a   Nakkula, Robin J ^a   Walters, John D ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b Immunology and Medical Genetics   (United States)

Author keywords

Biological transport; Ciprofloxacin therapeutic use; Minocycline therapeutic use

Indexed keywords

ADENINE; ANTIBIOTIC AGENT; CATION; CELL PROTEIN; CIPROFLOXACIN; DIAZEPAM; DOXYCYCLINE; HISTAMINE; MINOCYCLINE; MOXIFLOXACIN; OFLOXACIN; PAPAVERINE; PHENYLEPHRINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SODIUM ION; TETRACYCLINE;

ACTIVE TRANSPORT; ARTICLE; ASSAY; CELL LEVEL; CELL MEMBRANE TRANSPORT; COMPETITIVE INHIBITION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ACCUMULATION; DRUG TRANSPORT; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; LOW TEMPERATURE; MODEL; MONOLAYER CULTURE; MOUTH MUCOSA; MUCOSA CELL; PH; VELOCITY;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; CARCINOMA, SQUAMOUS CELL; CIPROFLOXACIN; EPITHELIAL CELLS; GINGIVA; HUMANS; LEAST-SQUARES ANALYSIS; MINOCYCLINE; MODELS, BIOLOGICAL; TUMOR CELLS, CULTURED;

EID: 0036867440     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2002.73.11.1267     Document Type: Article

References (33)

1. Meyer DH, Sreenivasan PK, Fives-Taylor PM. Evidence for invasion of a human oral cell line by Actinobacillus actinomycetemcomitans. Infect Immun 1991;59:2719-2726.
2. Meyer DH, Lippmann JE, Fives-Taylor PM. Invasion of epithelial cells by Actinobacillus actinomycetemcomitans: A dynamic, multistep process. Infect Immun 1996; 64:2988-2997.
3. Lamont RJ, Oda D, Persson RE, Persson GR. Interaction of Porphyromonas gingivalis with gingival epithelial cells maintained in culture. Oral Microbiol Immunol 1992;7: 364-367.
4. Lamont RJ, Chan A, Belton CM, Izutsu KT, Vasel D, Weinberg A. Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun 1995;63:3878-3885.
5. van Winkelhoff AJ, Rams TE, Slots J. Systemic antibiotic therapy in periodontics. Periodontol 2000 1996;10: 45-78.
6. Chadwick PR, Mellersh AR. The use of a tissue culture model to assess the penetration of antibiotics into epithelial cells. J Antimicrob Chemother 1987;19:211-220.
7. Bryan LE, Bedard J, Wong S, Chamberland S. Quinolone antimicrobial agents: Mechanism of action and resistance development. Clin Invest Med 1989;12:14-19.
8. Sanders CC. Microbiology of fluoroquinolones. In: Sanders WE, Sanders CC, eds. Fluoroquinolones in the Treatment of Infectious Diseases. Glenview, IL: Physicians and Scientists Publishing; 1990:1-27.
9. Goldman RA, Hasan T, Hall CC, Strycharz WA, Cooperman BS. Photoincorporation of tetracycline into E. coli ribosomes. Identification of the major proteins photolabeled by native tetracycline and tetracycline photo-products and implications for the inhibitory action of tetracycline on protein synthesis. Biochemistry 1983;22: 358-367.
10. Pavicic MJ, van Winkelhoff AJ, de Graaff J. In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations. Antimicrob Agents Chemother 1992;36:2634-2638.
11. Pajukanta R, Asikainen S, Saarela M, Alaluusua S, Jousimies-Somer H. In vitro antimicrobial susceptibility of different serotypes of Actinobacillus actinomycetemcomitans. Scand J Dent Res 1993;101:299-303.
12. Walker CB, Gordon JM, McQuilkin SJ, Niebloom TA, Socransky SS. Tetracycline: Levels achievable in gingival crevice fluid and in vitro effects on subgingival organisms. II. Susceptibilities of periodontal bacteria. J Periodontol 1981;52:613-616.
13. Walker CB, Pappas JD, Tyler KZ, Cohen S, Gordon JM. Antibiotic susceptibilities of periodontal bacteria. In vitro susceptibilities to eight antimicrobial agents. J Periodontol 1985;56(Suppl.):67-74.
14. Rheinwald JF, Beckett MA. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res 1981;41:1657-1663.
15. Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-254.
16. Gazzola GC, Dall'Asta V, Franchi-Gazzola R, White MF. The cluster-tray method for rapid measurement of solute fluxes in adherent cultured cells. Anal Biochem 1981; 115:368-374.
17. Walters JD, Zhang F, Nakkula RJ. Mechanisms of fluoroquinolone transport by human neutrophils. Antimicrob Agents Chemother 1999;43:2710-2715.
18. Lever M. Improved fluorometric determination of tetracyclines. Biochem Med 1972;6:216-222.
19. Garraffo R, Jambou D, Chichmanian RM, Ravoire S, Lapalus P. In vitro and in vivo ciprofloxacin pharmaco-kinetics in human neutrophils. Antimicrob Agents Chemother 1991;35:2215-2218.
20. Bounds SJ, Nakkula R, Walters JD. Fluoroquinolone transport by human monocytes: Characterization and comparison to other cells of myeloid lineage. Antimicrob Agents Chemother 2000;44:2609-2614.
21. Goldstein E, Citron DM, Hudspeth M, Gerardo SH, Merriam CV. In vitro activity of BAY 12-8039, a new 8-methoxyquinolone, compared to activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infection in humans. Antimicrob Agents Chemother 1997;41:1552-1557.
22. Pascual A, Garcia I, Ballesta S, Perea EJ. Uptake and intracellular activity of trovafloxacin in human phagocytes and tissue-cultured epithelial cells. Antimicrob Agents Chemother 1997;41:274-277.
23. Pascual A, Garcia I, Ballesta S, Perea EJ. Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells. Antimicrob Agents Chemother 1999;43:12-15.
24. Gabler WL. Fluxes and accumulation of tetracyclines by human blood cells. Res Commun Chem Pathol Pharmacol 1991;72:39-51.
25. Kleinberg I, Hall G. pH and depth of gingival crevices in different areas of the mouths of fasting humans. J Periodont Res 1968;3:109-117.
26. Borden SM, Golub LM, Kleinberg I. The effect of age and sex on the relationship between crevicular fluid flow and gingival inflammation in humans. J Periodont Res 1977;12:160-165.
27. Bickel M, Cimasoni G. The pH of human crevicular fluid measured by a new microanalytical technique. J Periodont Res 1985;20:35-40.
28. Griffith DA, Jarvis SM. Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1996;1286:153-181.
29. Koepsell H. Organic cation transporters in intestine, kidney, liver and brain. Annu Rev Physiol 1998;60:243-266.
30. Dresser MJ, Zhang L, Giacomini KM. Molecular and functional characteristics of cloned human organic cation transporters. Pharmaceutical Biotechnol 1999;12:441-469.
31. Goodson J, Offenbacher S, Farr D, et al. Periodontal disease treatment by local drug delivery. J Periodontol 1985;56:265-272.
32. Williams RC, Paquette DW, Offenbacher S, et al. Treatment of periodontitis by local administration of minocycline microspheres: A controlled trial. J Periodontol 2001; 72:1535-1544.
33. Kimura S, Toda H, Shimabukuro Y, et al. Topical chemotherapy in human periodontitis using a new controlled-release insert containing ofloxacin. 1. Microbiological observation. J Periodont Res 1991;26:33-41.